{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:45:38Z","timestamp":1761540338977},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p>The capability of von Willebrand factor (VWF) to bind platelet glycoprotein Ib (GPIb) and promote platelet plug formation is currently evaluated <jats:italic>in vitro<\/jats:italic> using the ristocetin co\u2010factor activity (VWF:RCo) assay. The replacement of this cumbersome and not always reproducible test with the collagen binding activity of VWF (VWF:CBA) has been attempted with controversial results. To evaluate the capacity of VWF:CBA to identify classic and variant von Willebrand disease (VWD) compared with VWF:RCo, we studied 10 type 2A and 12 type 2B VWD patients, together with 30 type 1 VWD patients with reduced platelet VWF content. In both 2A and 2B VWD, VWF:CBA and VWF:RCo were decreased, but that of VWF:CBA was more consistent. The difference was more evident when values were expressed as a ratio, obtained by normalizing VWF:CBA and VWF:RCo with the VWF antigen value; the ratio for VWF:CBA was always below 0\u00b72, while that for VWF:RCo was greater than 0\u00b74, and in no patient was the VWF:CBA value higher than VWF:RCo. In contrast, in type 1 VWD, the decrease in VWF:CBA was similar to that seen in VWF:RCo with the ratios always within the normal range. To better investigate the relationship between VWF:CBA and VWF:RCo, and the representation of large\/intermediate VWF multimers, to which both tests are sensitive, 1\u2010deamino\u2010cys\u20108\u2010<jats:sc>D<\/jats:sc>\u2010arginine\u2010vasopressin (DDAVP) was infused in type 2A and 2B VWD patients. The differences between the two tests were even more evident after DDAVP, and in type 2A, even though large multimers were persistently decreased, VWF:RCo was normalized, while VWF:CBA remained defective. These findings clearly indicate that VWF:CBA detects the absence of large and intermediate VWF multimers better than VWF:RCo. Hence, we suggest adding VWF:CBA to the panel of tests employed in the diagnosis of VWD. Moreover, owing to the difficulty in performing VWF:RCo and its low reproducibility, we suggest that, when necessary, VWF:CBA may be substituted for VWF:RCo.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02597.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:31:41Z","timestamp":1047364301000},"page":"578-583","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co\u2010factor activity?"],"prefix":"10.1111","volume":"112","author":[{"given":"A.","family":"Casonato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pontara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bertomoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sartorello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Cattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Girolami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01064.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(86)90150-7"},{"key":"e_1_2_6_4_1","first-page":"309","article-title":"The evaluation of factor VIII antigen by means of a simple slide test","volume":"29","author":"Casonato A.","year":"1985","journal-title":"American Journal of Clinical Pathology"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199204000-00003"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(97)90147-5"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/109.3.347"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1055\/s-0037-1614616","article-title":"Which assay is the most suitable to investigate von Willebrand factor functional activity?","volume":"81","author":"Casonato A.","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.16.6306"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199104000-00011"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830450303"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1055\/s-0037-1614375","article-title":"Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi\u2010laboratory survey","volume":"82","author":"Favaloro J.E.","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/S0021-9258(18)47430-3","article-title":"A major binding domain resides within the amino\u2010terminal 272 amino acid residues of von Willebrand factor","volume":"262","author":"Foster P.A.","year":"1987","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.17.5968"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3240185"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0038-1650400","article-title":"A3 domain is essential for interaction of von Willebrand factor with collagen type III","volume":"75","author":"Lankhof H.","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.5.3033"},{"key":"e_1_2_6_18_1","first-page":"306","article-title":"A method for assaying von Willebrand factor (ristocetin co\u2010factor)","volume":"34","author":"McFarlane D.E.","year":"1975","journal-title":"Thrombosis and Diathesis Haemorragica"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"17901","DOI":"10.1016\/S0021-9258(19)81299-1","article-title":"Structure of the von Willebrand factor domain interacting with glycoprotein Ib","volume":"263","author":"Mohri H.","year":"1988","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.2.454.454"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109795"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V70.4.895.895"},{"key":"e_1_2_6_23_1","first-page":"520","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler J.E.","year":"1994","journal-title":"For the Subcommittee on Von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.67.1.395"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/blood.V84.3.676.676","article-title":"Commentary: a new classification for von Willebrand disease","volume":"84","author":"Sadler J.E.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V65.4.823.823","article-title":"Factor VIII\/von Willebrand factor in subendothelium mediates platelet adhesion","volume":"65","author":"Turitto V.T.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_6_27_1","first-page":"152","article-title":"Determination of the von Willebrand's disease antigen (Factor VIII\u2010related antigen) in plasma by quantitative immunoelectrophoresis","volume":"86","author":"Zimmerman T.S.","year":"1975","journal-title":"Journal of Laboratory and Clinical Medicine"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02597.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02597.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02597.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:31:17Z","timestamp":1697535077000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02597.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02597.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02597.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}